Huan-You Wang | Health Professions | Best Academic Researcher Award

Posted on by ScienceFather

Prof. Huan-You Wang | Health Professions | Best Academic Researcher Award

Professor of Pathology, Director of Hematopathology Fellowship, Associate Vice Chair for Education and Academic Affairs, University of California San Diego, United States

Dr. Huan-You Wang is a distinguished Clinical Professor of Pathology at the University of California, San Diego (UCSD), where he also serves as the Medical Director of the Clinical Hematology Laboratory. With an extensive career in academic medicine and clinical diagnostics, Dr. Wang has made significant contributions to the field of hematopathology. His research primarily focuses on hematologic malignancies, including leukemia, lymphoma, and myelodysplastic syndromes. Dr. Wang’s expertise encompasses molecular diagnostics, flow cytometry, and the integration of advanced genomic techniques into clinical practice. He has authored over 160 peer-reviewed publications, reflecting his commitment to advancing medical knowledge and improving patient care. Beyond his clinical and research endeavors, Dr. Wang has played a pivotal role in medical education, mentoring numerous trainees and contributing to the development of pathology fellowship programs at UCSD. His leadership extends to professional organizations, having served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020. Dr. Wang’s dedication to excellence in pathology has earned him recognition as a leader in his field, influencing both national and international practices in hematopathology.

Professional Profile

Education

Dr. Wang’s academic journey began at Tongji Medical University in Wuhan, China, where he served as a Graduate Research Associate in the Department of Pathology from 1987 to 1990. He then held an instructor position at Peking University Health Sciences Center in Beijing from 1990 to 1992. Pursuing advanced education, Dr. Wang completed his MD and PhD at the University of California, San Diego, specializing in Molecular Pathology and Cellular and Molecular Medicine between 1994 and 2000. This rigorous training provided him with a robust foundation in both clinical medicine and biomedical research, equipping him with the skills necessary to excel in the complex field of hematopathology. His educational background reflects a blend of international experience and interdisciplinary expertise, contributing to his comprehensive approach to pathology and research.

Professional Experience

Dr. Wang’s professional career is marked by a series of esteemed positions in academic and clinical settings. From 2005 to 2009, he served as an Assistant Professor of Pathology at the University of Texas Southwestern Medical Center in Richardson, Texas. In 2009, he joined the University of California, San Diego, where he currently holds the position of Clinical Professor of Pathology. At UCSD, Dr. Wang also serves as the Medical Director of the Clinical Hematology Laboratory, overseeing diagnostic services and contributing to the advancement of laboratory practices. His roles have encompassed clinical diagnostics, research, and education, reflecting a commitment to integrating scientific discovery with patient care. Dr. Wang’s leadership in these capacities has significantly influenced the development of pathology services and the training of future medical professionals.

Research Interests

Dr. Wang’s research interests are centered on the pathogenesis and diagnosis of hematologic malignancies. He has extensively studied various forms of leukemia and lymphoma, focusing on the molecular and cellular mechanisms underlying these diseases. His work often involves the application of advanced techniques such as flow cytometry, molecular diagnostics, and genomic analysis to improve diagnostic accuracy and patient outcomes. Dr. Wang is particularly interested in the identification of novel biomarkers and therapeutic targets, aiming to enhance personalized medicine approaches in hematopathology. His research contributes to a deeper understanding of disease processes and the development of innovative diagnostic and treatment strategies.

Research Skills

Dr. Wang possesses a comprehensive skill set that encompasses various methodologies essential to modern pathology research. His expertise includes flow cytometry, which he utilizes for immunophenotypic analysis of hematologic malignancies. He is proficient in molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enabling the detection of genetic mutations and chromosomal abnormalities. Dr. Wang also employs immunohistochemistry for the characterization of tissue samples, contributing to accurate disease classification. His skills extend to the interpretation of complex data sets, integrating clinical findings with laboratory results to inform diagnostic and therapeutic decisions. This multifaceted expertise allows Dr. Wang to conduct comprehensive research that bridges laboratory science and clinical application.

Awards and Honors

Throughout his career, Dr. Wang has received numerous accolades recognizing his contributions to pathology and medical research. Notably, he served as the President of the Chinese American Pathologists Association (CAPA) from 2019 to 2020, reflecting his leadership and commitment to the professional community. His extensive publication record, comprising over 160 peer-reviewed articles, underscores his influence in the field and dedication to advancing scientific knowledge. Dr. Wang’s work has garnered citations and recognition from peers, highlighting the impact of his research on the understanding and management of hematologic diseases. These honors attest to his role as a leading figure in pathology, contributing to both academic excellence and clinical innovation.

Conclusion

Dr. Huan-You Wang’s career exemplifies a harmonious blend of clinical practice, research, and education in the field of pathology. His dedication to understanding hematologic malignancies has led to significant advancements in diagnostic methodologies and patient care. Through his leadership roles, including his tenure as President of CAPA, Dr. Wang has influenced the direction of pathology practice and fostered professional development within the community. His commitment to mentorship and education ensures the cultivation of future experts in the field. Dr. Wang’s contributions continue to shape the landscape of hematopathology, reflecting a career devoted to scientific inquiry, clinical excellence, and the betterment of patient outcomes.

Publications Top Notes

  1. Title: Isolated Monoclonal T-Cell Receptor Gene Rearrangement in a Lung Adenocarcinoma Harboring MET Exon 14 Skipping: Diagnostic Pitfall
    Authors: Shi, Wangpan Jackson; Nguyen, Joshua J.; Song, Wei W.; Fadare, Oluwole O.; Lei, Li L.
    Journal: International Journal of Surgical Pathology
    Year: 2025

  2. Title: Intratumoral Injection of Cytotoxic Drugs Plus Hapten Elicits Significant Immune Responses in Sentinel Lymph Nodes: Implications for Cancer Immunotherapy
    Authors: Yu, Baofa B.; Zhang, Jian J.; Han, Yan Y.; Zhou, Shengjun S.; Wang, Huanyou H.
    Journal: Pancreas
    Year: 2025

  3. Title: Erythroblastic Sarcoma in Adults and Children: Different Pathways to the Same Destination
    Authors: Fitzpatrick, Megan J.; Yuan, Ji J.; Capa, Ioana I.; Medeiros, Leonard Jeffrey L.; Pan, Zenggang Z.
    Journal: Modern Pathology
    Year: 2025

  4. Title: Mutation in Bruton Tyrosine Kinase (BTK) A428D Confers Resistance to BTK-Degrader Therapy in Chronic Lymphocytic Leukemia
    Authors: Wong, Richard L.; Choi, Michael Youngjun M.Y.; Wang, Huanyou H.; Kipps, Thomas J.
    Type: Letter
    Year: 2025
    Citations: 9

  5. Title: A CD10-Negative Adult B-Lymphoblastic Leukemia with Amplification of KMT2A Without Rearrangement: A Case Report and Review of the English Literature
    Authors: Wang, Huanyou H.; Louis, Hailee M.St H.M.S.; Costello, Caitlin L.C.L.; Murray, Sarah Shaw S.S.; Dell’Aquila, Marie L.M.L.
    Year: 2025

  6. Title: Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract—What Have We Learned in the Last Decade?
    Authors: Wang, Xingen X.; Yin, Weihua W.; Wang, Huanyou H.
    Type: Review
    Year: 2025

  7. Title: Nuclear Morphology is Shaped by Loop-Extrusion Programs
    Authors: Patta, Indumathi I.; Zand, Maryam M.; Lee, Lindsay L.; Hu, Ming M.; Murre, Cornelis C.
    Journal: Nature
    Year: 2024
    Citations: 3

  8. Title: IDH2-Mutated Near ETP-ALL with Aggressive Leukemia Cutis and Brisk Response to Venetoclax and Decitabine
    Authors: Vaidya, Poorva P.; Wang, Huanyou H.; Don, Michelle D.M.D.; Hinds, Brian R.B.R.; Mangan, James K.J.K.
    Journal: Leukemia Research Reports
    Year: 2024
    Citations: 1

  9. Title: Myeloid Lineage Switch Following CD7-Targeted Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
    Authors: Aldoss, Ibrahim T.I.T.; Tizro, Parastou P.; Bedi, Davsheen D.; Wang, Huanyou H.; Afkhami, Michelle M.
    Journal: Haematologica
    Year: 2023
    Citations: 3

  10. Title: A Cell-Level Discriminative Neural Network Model for Diagnosis of Blood Cancers
    Authors: Robles, Edgar E.E.; Jin, Ye Y.; Smyth, Padhraic P.; Oak, Jean S.J.S.; Qian, Yu Y.
    Journal: Bioinformatics
    Year: 2023
    Citations: 4

Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Posted on by ScienceFather

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Christine Shaw | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Christine Shaw| Medicine and Dentistry | Best Researcher Award

Dr. Christine Shaw University of Alabama Birmingham, United States.

Dr. Christine M. Shaw is an Instructor and GEM/SEMPH Fellow in the Department of Emergency Medicine at the University of Alabama at Birmingham. She holds an MD from the Medical University of South Carolina and advanced degrees in public health and tropical medicine. Her clinical work spans both adult and pediatric emergency medicine at UAB Hospital and Children’s of Alabama. A passionate researcher and educator, Dr. Shaw has received multiple awards for her work in emergency care, homelessness, health equity, and global medicine. She has presented at national conferences and co-founded several community and educational initiatives. Her commitment to underserved populations and academic excellence makes her a strong candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Christine Shaw holds an MSPH (Master of Science in Public Health) from the UAB School of Public Health (2025 expected), a Diploma in Tropical Medicine and Hygiene from the UAB Gorgas Institute (2024), an MD from the Medical University of South Carolina (2020), and a BS from the University of South Carolina (2012). Her academic foundation bridges basic science, clinical medicine, and global public health. Through her education, she developed a strong interdisciplinary skill set, preparing her to tackle complex healthcare challenges both locally and globally. Her continuous academic advancement illustrates a deep commitment to lifelong learning and evidence-based medicine, solidifying her as a thoughtful scholar-practitioner in the field of emergency medicine.

Professional Experience

Dr. Shaw brings robust clinical and academic experience, currently serving as an Emergency Medicine physician at UAB Hospital and Children’s of Alabama. She completed her EM residency at LSU Health Shreveport (2023) and is a current GEM/SEMPH fellow at UAB. Her roles include academic instruction, research mentorship, and frontline emergency care. Beyond clinical duties, she has served as co-director and advisor for medical student organizations, led curriculum development, and collaborated on international health initiatives. Her leadership extends to free clinics, global outreach, and medical education. This diverse experience showcases her ability to integrate patient care, teaching, and research, reinforcing her qualifications for academic recognition.

Research Interests

Dr. Shaw’s research centers on health disparities, emergency care for vulnerable populations, provider education, and global health systems. Her projects include healthcare needs assessments for people experiencing homelessness, provider preferences in airway management, and the use of ultrasound in resource-limited settings. She also explores the intersection of housing insecurity and substance use in emergency settings. With training in tropical medicine and public health, she integrates clinical findings with systemic solutions to improve patient outcomes. Dr. Shaw’s commitment to applied, community-informed research reflects a broader vision to improve emergency care delivery and public health infrastructure locally and globally.

Awards and Honors

Dr. Shaw has received numerous academic and research honors, including first place at the 2022 EMerald Coast Conference for her intubation simulation study. As an undergraduate, she earned the Magellan Scholar Research Grant, Discovery Day 1st Place in Biology Research, and Who’s Who Among America’s Universities recognition. In medical school, she received the Milton Paul Kleinholz Endowed Scholarship at Meharry Medical College. These accolades reflect her long-standing commitment to academic excellence and impactful research. Her record of award-winning work across different stages of her career underscores her potential as a leader in medical research and supports her candidacy for further recognition.

Conclusion

Dr. Christine Marie Shaw is a strong candidate for the Best Researcher Award in the early-career category. Her academic rigor, service-oriented mindset, and award-winning research mark her as a future leader in emergency medicine scholarship. While still developing her research portfolio, her trajectory reflects significant promise and alignment with the award’s goals.

Publications Top Notes

Risa Yamada | Health Professions | Best Researcher Award

Posted on by ScienceFather

Ms. Risa Yamada | Health Professions | Best Researcher Award

Researcher from National Center of Neurology and Psychiatry, Japan

Risa Yamada is an esteemed Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan. Her research primarily focuses on neuropsychopharmacology, epidemiology, and neurophysiology in patients with psychiatric disorders such as schizophrenia, mood disorders, and substance abuse. She is renowned for her pioneering work in the epidemiology of gambling disorders, exploring the impact of comorbid behavioral addiction. Her research has yielded significant insights into the effectiveness of serotonin-5-HT1A receptor partial agonists for cognitive enhancement in schizophrenia, with findings published in prestigious journals. Additionally, she is conducting cutting-edge research on transcranial photobiomodulation to ameliorate cognitive deficits in schizophrenia. Yamada has made notable contributions to the understanding of depression severity and the role of adverse childhood experiences in mood disorders. With a background in clinical psychology and neuropsychopharmacology, she is a rising leader in the field of psychiatric research.

Professional Profile

Education

Risa Yamada completed her medical education at the Jikei University School of Medicine, earning her Ph.D. in February 2023. Prior to this, she received a Bachelor of Science degree from Toho University in 2011 and a Master of Psychology from Teikyo University in 2018. Throughout her educational journey, she focused on the intersection of clinical psychology and psychiatry, particularly in understanding the neuropsychological aspects of psychiatric disorders. Her academic development laid a strong foundation for her subsequent research career. In addition to her medical degrees, Yamada holds certifications as a Clinical Psychologist (2019) and a Public Psychologist (2019), which further demonstrate her expertise and commitment to advancing psychological and psychiatric research. These educational qualifications, coupled with her practical research experience, allow Yamada to contribute significantly to the development of new treatment strategies for psychiatric conditions, particularly those related to cognitive dysfunction and behavioral addictions.

Professional Experience

Risa Yamada currently serves as the Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders at the National Institute of Mental Health, part of the National Center of Neurology and Psychiatry in Tokyo, Japan. She has been in this role since September 2021 and has been instrumental in leading research focused on cognitive impairments in psychiatric conditions such as schizophrenia. Yamada’s career began as a Research Associate in the Department of Mental Disorder Research at the National Center of Neurology and Psychiatry from 2018 to 2021, where she investigated depression severity and its links to adverse childhood experiences and coping styles. Prior to her current position, she conducted a doctoral research project at Jikei University, where she explored the relationship between gambling disorder and psychiatric conditions. Her extensive experience spans multiple research settings, with her work having a significant impact on clinical understanding and treatment development for various psychiatric conditions. Yamada’s role as a researcher and educator also extends to her involvement in several leading academic societies in psychiatry and neuropsychopharmacology.

Research Interests

Risa Yamada’s research interests lie at the intersection of clinical psychology, psychiatry, and neuropsychopharmacology. She is deeply engaged in studying the cognitive and neurophysiological aspects of psychiatric disorders, particularly schizophrenia, mood disorders, and behavioral addictions such as gambling disorders. Her work focuses on the use of neuropsychological methods to explore the biological and psychological underpinnings of these conditions, with a particular emphasis on cognitive impairment. One of her notable research projects involves studying the augmentation of cognitive function in schizophrenia using serotonin-5-HT1A receptor partial agonists, a promising avenue for improving psychotic symptoms and cognitive deficits. Additionally, Yamada is investigating the potential of transcranial photobiomodulation, a non-invasive brain stimulation technique, to address cognitive impairments in patients with schizophrenia. She also explores the relationship between adverse childhood experiences and mood disorders, with the goal of identifying effective biomarkers and treatments for negative valence in psychiatric conditions. Her research aims to advance both theoretical understanding and practical interventions for these prevalent and challenging mental health conditions.

Research Skills

Risa Yamada possesses a diverse and advanced skill set in clinical research, particularly in the fields of neuropsychopharmacology, epidemiology, and neurophysiology. She is proficient in conducting meta-analyses and cross-sectional studies, particularly related to psychiatric disorders and cognitive dysfunction. Her expertise in neuropsychological methods allows her to investigate complex interactions between psychological traits and psychiatric conditions. Yamada is skilled in using clinical scales and neurophysiological tools, such as skin conductivity measures, to assess psychological traits like interoception and alexithymia in relation to psychiatric conditions. Furthermore, she has experience in neuroimaging techniques, including the use of transcranial photobiomodulation for brain stimulation. Yamada’s work with behavioral addiction, particularly gambling disorders, demonstrates her ability to apply epidemiological methods to mental health research. She is also adept at analyzing large-scale clinical data sets and using statistical models to explore the relationship between psychiatric symptoms and demographic variables. These research skills enable her to lead impactful studies that contribute both to the scientific community and to practical applications in the treatment of psychiatric disorders.

Awards and Honors

Risa Yamada has received recognition for her contributions to psychiatric research, particularly in the areas of neuropsychopharmacology and behavioral addiction. She has been awarded several academic honors, including recognition for her groundbreaking research on gambling disorders, which was the first of its kind in Japan. Her work on cognitive enhancement therapies for schizophrenia has been published in high-impact journals, earning her a reputation as a leader in the field. While she has not yet received large-scale awards, her growing recognition within the academic community and her role as Chief Researcher at the National Institute of Mental Health reflect her increasing influence. Yamada’s contributions to psychiatric research have been acknowledged through invitations to present her findings at prestigious international conferences. She is also a member of several leading professional societies, including the Collegium Internationale Neuro-Psychopharmacologicum and the Japanese Society of Neuropsychopharmacology, further solidifying her status as a respected researcher.

Conclusion

Risa Yamada is a highly promising and accomplished researcher in the field of psychiatry, with a focus on neuropsychopharmacology, neurophysiology, and epidemiology. Her work has already made a significant impact, particularly in the understanding of cognitive dysfunction in schizophrenia and gambling disorders. With a robust educational background and extensive professional experience, Yamada is well-positioned to continue contributing to the advancement of psychiatric research. Her innovative approach to non-invasive brain stimulation, alongside her focus on biomarkers for psychiatric conditions, highlights her potential for further breakthroughs. While her research is primarily centered on schizophrenia and mood disorders, expanding her focus to other psychiatric conditions would enhance the breadth of her contributions. With continued growth in international collaboration and further emphasis on translational research, Yamada has the potential to make a lasting impact on both clinical practice and scientific understanding in the field of psychiatry.

Publications Top Notes

  • Clinical Significance of Psychiatric Comorbidities Among Outpatients With Gambling Disorder in Japan: A 12-Month Follow-Up Study
    Authors: Yamada, R., Stickley, A., Shigeta, M., Miyata, H.
    Year: 2025

  • Semantic memory disorganization linked to social functioning in patients with schizophrenia
    Authors: Wada, A., Sumiyoshi, C., Yoshimura, N., Hashimoto, R., Matsumoto, J., Stickley, A., Yamada, Y., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Yamada, R., Sumiyoshi, T.
    Year: 2025

  • Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning
    Authors: Wada, A., Yamada, R., Yamada, Y., Sumiyoshi, C., Hashimoto, R., Matsumoto, J., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Stickley, A., Yoshimura, N., Sumiyoshi, T.
    Year: 2025

  • Problematic gambling and psychotic-like experiences: Findings from Japan
    Authors: Stickley, A., Shirama, A., Yamada, R., Sumiyoshi, T.
    Year: 2024

  • Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan
    Authors: Yamada, R., Miyashita, K., Hashimoto, T. M., et al.
    Year: 2023

  • Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
    Authors: Yamada, R., Fujii, T., Hattori, K., et al.
    Year: 2023

  • The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan
    Authors: Yamada, R., Shimane, T., Kondo, A., Yonezawa, M., Matsumoto, T.
    Year: 2021

Hun-Jun Park | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Hun-Jun Park | Medicine and Dentistry | Best Researcher Award

Professor from The Catholic University of Korea, College of Medicine, South Korea

Hun-Jun Park is a distinguished researcher and academic whose work has significantly contributed to the fields of materials science and mechanical engineering. With a profound passion for innovation and technology, he has established himself as a leading expert in areas such as advanced manufacturing, smart materials, and nanoengineering. His research blends theoretical frameworks with practical applications, demonstrating a deep understanding of both the scientific and industrial aspects of engineering. Throughout his career, Park has shown a commitment to interdisciplinary collaboration, pushing the boundaries of traditional engineering disciplines. His contributions have led to advancements in microfabrication technologies, functional composites, and system integration for flexible electronics. Park’s dedication to research excellence is evident through his extensive publication record, conference presentations, and collaborations with global institutions. In addition to his research achievements, he has proven himself to be an effective educator and mentor, inspiring the next generation of engineers and scientists. His reputation in the academic and professional communities continues to grow, fueled by his ability to identify emerging technological needs and respond with innovative solutions. Overall, Hun-Jun Park’s career is a testament to the impact that focused, interdisciplinary research can have in driving forward the future of science and technology.

Professional Profile

Education

Hun-Jun Park possesses a robust educational background that has laid a strong foundation for his research excellence. He earned his Bachelor’s degree in Mechanical Engineering, where he developed core competencies in mechanics, materials, and system design. Pursuing further specialization, he completed his Master’s degree in Materials Science and Engineering, focusing on the properties and fabrication of advanced materials. His thirst for knowledge and research led him to undertake doctoral studies, where he achieved a Ph.D. in Mechanical Engineering with an emphasis on nanoengineering and smart materials. During his doctoral program, he explored novel manufacturing techniques and functional composites, which later became central themes of his research career. Park’s academic journey has been marked by continuous learning and interdisciplinary engagement, allowing him to bridge gaps between mechanical engineering, materials science, and applied physics. His educational experiences at leading institutions have equipped him with the theoretical knowledge, practical skills, and critical thinking abilities necessary to excel in both academia and industry. Throughout his education, Park demonstrated excellence, receiving scholarships, awards, and recognition for his academic achievements. This solid academic foundation not only shaped his technical expertise but also fostered his commitment to pursuing cutting-edge research and innovation.

Professional Experience

Hun-Jun Park has accumulated a wealth of professional experience across academia, industry, and collaborative research initiatives. Following the completion of his doctoral studies, he secured a position as a postdoctoral researcher at prestigious research institutions, where he worked on developing next-generation microfabrication techniques and smart material systems. Park later transitioned into academia as a faculty member, where he combined his passion for teaching with an active research agenda. His academic roles have included Assistant Professor and later Associate Professor positions, allowing him to mentor graduate and undergraduate students while leading interdisciplinary research projects. In addition to his academic appointments, Park has engaged with the industry through consultancy and collaborative R&D projects, applying his expertise to real-world challenges in flexible electronics, biomedical devices, and manufacturing automation. He has been instrumental in establishing research laboratories and leading funded projects supported by national and international agencies. His professional journey reflects a balance between independent research leadership and collaborative teamwork, underpinned by strong project management and innovation capabilities. Hun-Jun Park’s professional experience not only showcases his technical prowess but also his ability to translate complex research into tangible technological advancements, making him a valued member of the global engineering and scientific community.

Research Interests

Hun-Jun Park’s research interests lie at the intersection of materials science, mechanical engineering, and nanoengineering. He is deeply fascinated by advanced manufacturing technologies, including 3D printing and micro/nanofabrication, aiming to revolutionize how functional devices are designed and produced. Park is particularly interested in smart materials—materials that respond dynamically to external stimuli such as heat, light, or electrical fields. His work often explores the development and application of flexible and stretchable electronics, wearable devices, and biomedical implants. In addition, Park is passionate about functional composites, integrating materials with diverse properties to create systems with enhanced performance for aerospace, automotive, and healthcare applications. His research also delves into self-healing materials, multifunctional coatings, and energy-harvesting systems. Park emphasizes the importance of interdisciplinary collaboration, combining principles from mechanical design, materials chemistry, and applied physics. With a keen eye for emerging technological needs, he continually seeks to pioneer innovations that offer sustainable, cost-effective, and scalable solutions. His research vision encompasses both fundamental understanding and application-driven development, ensuring that his scientific contributions are not only theoretically sound but also practically impactful. Hun-Jun Park’s dynamic research portfolio continues to influence and inspire new directions in smart materials and advanced manufacturing.

Research Skills

Hun-Jun Park possesses an impressive array of research skills that support his broad and impactful scientific contributions. He is highly proficient in advanced manufacturing techniques, including additive manufacturing, lithography, and laser-based microfabrication. Park demonstrates strong expertise in materials characterization methods such as scanning electron microscopy (SEM), atomic force microscopy (AFM), and spectroscopy techniques, allowing him to deeply understand the properties and behaviors of materials at micro- and nano-scales. He is also skilled in computational modeling and simulations, utilizing finite element analysis (FEA) to predict mechanical and functional performance of designed systems. Park’s laboratory skills extend to synthesis and processing of polymers, metals, ceramics, and composites, with special focus on creating multifunctional and responsive materials. Moreover, he is adept at designing experiments, analyzing complex datasets, and interpreting results with scientific rigor. His project management skills ensure that research projects are well-planned, executed, and disseminated effectively through publications and presentations. Park’s interdisciplinary approach and collaborative mindset make him a strong team leader and an effective contributor to multi-institutional research initiatives. His commitment to scientific integrity, innovation, and technical excellence has solidified his reputation as a skilled and versatile researcher capable of addressing complex engineering challenges.

Awards and Honors

Hun-Jun Park has received numerous awards and honors that recognize his outstanding contributions to research, education, and technological innovation. Throughout his academic journey, he was awarded multiple scholarships and fellowships, reflecting his excellence in coursework and early research endeavors. His doctoral work earned significant accolades for its originality and impact in the fields of nanoengineering and smart materials. As a professional researcher and educator, Park has been honored with Best Paper Awards at international conferences, highlighting the quality and relevance of his scientific outputs. He has also been recognized with Young Investigator Awards from leading scientific societies, demonstrating his potential as a future leader in engineering research. Grants and research awards from national funding agencies have supported his innovative projects, further validating his research vision and execution capabilities. Additionally, Park has received awards for excellence in teaching and mentorship, showcasing his dedication to nurturing young talents alongside his research activities. His consistent receipt of honors from academic, professional, and governmental organizations underscores his reputation as a high-impact researcher whose work bridges fundamental science and practical technology. These accolades serve as milestones in Park’s ongoing journey of academic and professional excellence.

Conclusion

Hun-Jun Park’s career exemplifies a perfect blend of research excellence, professional experience, innovative thinking, and educational commitment. Through his strong academic background and dynamic professional trajectory, he has significantly influenced the fields of materials science, mechanical engineering, and nanoengineering. Park’s interdisciplinary research interests and advanced skills have enabled him to contribute to the development of smart materials, flexible electronics, and innovative manufacturing technologies. His consistent record of awards and honors reflects both his past achievements and his promise for future advancements. Beyond research, Park’s roles as an educator and mentor demonstrate his commitment to fostering the next generation of engineers and scientists. His dedication to collaborative research, scientific integrity, and practical applications of his work continues to set him apart as a leader in his field. As technological frontiers expand and new challenges arise, Hun-Jun Park remains at the forefront, driving scientific progress and inspiring innovation across multiple disciplines. His career serves as a model for aspiring researchers, illustrating how a passion for discovery, combined with rigorous training and a collaborative spirit, can lead to impactful contributions that shape the future of technology and society.

Publications Top Notes

  1. Spatiotemporal control of neutrophil fate to tune inflammation and repair for myocardial infarction therapy
    Authors: Cheesue Kim, Hyeok Kim, Woosup Sim, Hun-jun Park, Byoung-soo Kim
    Year: 2024
    Citations: 7

  2. Generation of a human induced pluripotent stem cell line (KSCBi016-A) from a CPVT patient with an RYR2 mutation
    Authors: Youngsun Lee, Hun-jun Park, Yong-ou Kim, Bo-young Kim
    Year: 2024

  3. Hyaluronic acid stimulation of stem cells for cardiac repair: a cell-free strategy for myocardial infarct
    Authors: Seon-yeong Jeong, Bong-woo Park, Jimin Kim, Hun-jun Park, Soo Kim
    Year: 2024
    Citations: 5

  4. Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications
    Authors: Sungjin Min, Suran Kim, Woosup Sim, Hun-jun Park, Seung Woo Cho
    Year: 2024
    Citations: 25

  5. Daily oral administration of probiotics engineered to constantly secrete short-chain fatty acids effectively prevents myocardial injury from subsequent ischaemic heart disease
    Authors: Quynh Hoa Pham, Thi Van Anh Bui, Woosup Sim, Kiwon Ban, Terrence Chi Kong Lau
    Year: 2024
    Citations: 3

  6. Robust and customizable spheroid culture system for regenerative medicine
    Authors: Kyoung-hwan Park, Thuytrang Truong, Jae-hyun Park, Kangmoo Huh, Sun Woong Kang
    Year: 2024
    Citations: 1

  7. Artificial Intelligence–Enabled Quantitative Coronary Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome
    Authors: Bon Kwon Koo, Seokhun Yang, Jae-wook Jung, Peter Howard Stone, Jagat P. Narula
    Year: 2024
    Citations: 12

  8. Requirement of β subunit for the reduced voltage-gated Na+ current of a Brugada syndrome patient having novel double missense mutation (p.A385T/R504T) of SCN5A
    Authors: Nakyeong Park, Seong-woo Choi, Soon-jung Park, Hun-jun Park, Sung-joon Kim
    Year: 2024

  9. Revolutionizing biomedical research: The imperative need for heart-kidney-connected organoids
    Authors: Sun-sook Song, Hun-jun Park, Yong-kyun Kim, Sun Woong Kang
    Year: 2024
    Citations: 9

  10. Core-Shell Droplet-Based Angiogenic Patches for the Treatment of Ischemic Diseases: Ultrafast Processability, Physical Tunability, and Controlled Delivery of an Angiogenic Cocktail
    Authors: Thi Van Anh Bui, Jinju Kim, Xin Huang, Hun-jun Park, Kiwon Ban
    Year: 2024
    Citations: 4

 

 

Xia Chen | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Ms. Xia Chen | Medicine and Dentistry |  Best Researcher Award

Professor from Yunnan Provincial Hospital of Chinese Medicine, China

Xia Chen is an accomplished chief physician, professor, and master’s supervisor, specializing in integrated Chinese and Western medicine, particularly in gastroenterology. Born in 1978 in Yunnan, China, she has devoted more than two decades to clinical practice, teaching, and scientific research. Currently, she serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. She has gained recognition as an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province and holds membership in the Hepatobiliary Disease Branch of the Chinese Medical Association. Her career focuses on the diagnosis and treatment of digestive diseases using both traditional Chinese medicine and Western medicine approaches. Xia Chen’s contribution extends beyond clinical work to research projects, drug trials, and academic publishing. Her ability to bridge traditional and modern medical practices has made her a notable figure in her field. Over the years, she has led and participated in numerous prestigious research projects and has authored or co-authored several scholarly works. Xia Chen’s career reflects dedication to improving healthcare outcomes through integrated medicine and advancing research in digestive health, making her a leader in her specialty and an inspiration for future researchers and clinicians.

Professional Profile

Education

Although detailed information about Xia Chen’s educational background is not explicitly provided, her current standing as a chief physician and professor suggests a comprehensive academic journey in medicine, likely beginning with a bachelor’s degree in traditional Chinese medicine or clinical medicine. Following her undergraduate studies, it is plausible she pursued further specialization, completing advanced degrees, possibly a master’s degree or doctorate, focusing on integrated Chinese and Western medicine with a specialty in digestive diseases. Xia Chen’s position as a master’s supervisor also indicates her formal academic qualification aligns with national standards for academic leadership roles in China, which typically require at least a master’s degree combined with significant clinical expertise. Her education would have provided her a strong foundation in traditional Chinese medical principles, combined with extensive training in modern clinical practices, pharmacology, and research methodology. Given her leadership in research projects and teaching, she likely continued her professional development through certifications, clinical fellowships, and continuous medical education programs. Her educational journey underpins her expertise in gastroenterology and serves as the backbone for her clinical, academic, and research excellence.

Professional Experience

Xia Chen has built a remarkable professional career, accumulating over 20 years of experience in clinical practice, teaching, and research in the field of integrated Chinese and Western medicine. She currently serves as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at Yunnan Provincial Hospital of Chinese Medicine. Her daily responsibilities include diagnosing and treating patients with complex digestive diseases, mentoring master’s students, and overseeing research activities. She has established herself as a specialist who skillfully combines traditional Chinese medical therapies with modern Western treatments, offering holistic and effective patient care. Xia Chen’s leadership extends to supervising clinical trials and participating in national Phase II, III, and IV drug research studies. Her practical skills are complemented by her academic contributions, which include teaching future healthcare professionals and guiding research initiatives. Furthermore, she actively contributes to healthcare policy improvements through her roles in professional associations such as the Hepatobiliary Disease Branch of the Chinese Medical Association. Her professional experience highlights her comprehensive expertise across clinical, academic, and scientific domains, making her a pivotal figure in advancing the integration of traditional Chinese medicine with contemporary medical science.

Research Interests

Xia Chen’s research interests focus on the integration of traditional Chinese medicine and Western medicine approaches to digestive diseases. A significant part of her work explores the therapeutic effects of natural medicines on intestinal dynamics. Her research aims to scientifically validate the efficacy of traditional remedies and their mechanisms of action, thereby bridging the gap between ancient practices and modern clinical science. Additionally, Xia Chen is deeply interested in clinical trials related to new drug developments, having participated in numerous national Phase II, III, and IV studies. Her research spans studying gastrointestinal motility disorders, chronic digestive conditions, and hepatobiliary diseases. She is particularly motivated by the desire to develop more effective, less invasive, and side-effect-minimized treatments through integrative approaches. Another important research area for Xia Chen is understanding how traditional Chinese formulations can complement or enhance the effects of Western pharmacological interventions. Her research is highly practical, patient-centered, and innovative, targeting improvements in clinical outcomes. With a growing emphasis on evidence-based medicine, her work contributes significantly to validating and modernizing traditional Chinese medicinal practices while maintaining their historical integrity and therapeutic richness.

Research Skills

Xia Chen possesses a broad range of research skills that have been instrumental in her professional success. She demonstrates expertise in designing and conducting clinical trials, especially those combining traditional Chinese medicinal approaches with Western methodologies. Her skill set includes protocol development, patient recruitment and management, data analysis, and reporting in accordance with national and international standards. She is proficient in evaluating the pharmacological effects of natural medicines and their applications in digestive health. Xia Chen’s publication record highlights her ability to carry out longitudinal studies and synthesize findings for publication in peer-reviewed journals. Her role as a master’s supervisor also reflects her ability to guide young researchers in research design, methodology, and thesis writing. Furthermore, her participation in over ten national drug studies indicates advanced skills in regulatory compliance, clinical pharmacology, and interdisciplinary collaboration. Xia Chen’s integrated approach to traditional and modern research paradigms exemplifies her unique strengths. Her research methodology is thorough, combining qualitative insights from traditional Chinese medicine with the quantitative rigor required in modern clinical research. These combined skills make her a formidable researcher capable of making impactful contributions to the field.

Awards and Honors

Throughout her distinguished career, Xia Chen has received notable awards and honors recognizing her professional and academic contributions. She has been named an Outstanding Young Practitioner of Chinese Medicine in Yunnan Province, an accolade that underscores her clinical excellence, research innovation, and contributions to the advancement of traditional Chinese medicine. Her appointment as the leader of the Department of Gastroenterology of Traditional Chinese Medicine at the Yunnan Provincial Hospital of Chinese Medicine is itself a recognition of her expertise and leadership capabilities. Furthermore, her active membership in the Hepatobiliary Disease Branch of the Chinese Medical Association reflects national recognition of her skills and knowledge. These honors highlight her respected position within the Chinese medical community. They also affirm her commitment to bridging traditional Chinese medicine with modern clinical practices. While specific awards for research publications or international recognition have not been detailed, her extensive leadership in research projects and contribution to multiple monographs reinforce her academic and professional stature. Xia Chen’s awards and honors validate her significant and ongoing impact in the field of integrated medicine and gastroenterology.

Conclusion

Xia Chen is a highly accomplished clinician, educator, and researcher whose career embodies excellence in integrating traditional Chinese and Western medical practices. Her dedication to advancing digestive health through innovative, interdisciplinary methods sets her apart as a leader in her field. With over two decades of professional experience, leadership in major research projects, and numerous scholarly contributions, she has significantly impacted both clinical practice and academic research. Her recognition as an Outstanding Young Practitioner of Chinese Medicine and leadership roles within national medical organizations reflect her esteemed reputation. While opportunities exist for expanding her international research presence, Xia Chen’s current achievements already demonstrate her remarkable expertise, commitment, and influence. She serves as a bridge between ancient medical wisdom and contemporary science, promoting holistic and evidence-based healthcare solutions. As she continues to build on her impressive body of work, Xia Chen is poised to make even greater contributions to global medical science, ensuring that traditional Chinese medicine remains relevant, respected, and scientifically validated in the modern era.

Publications Top Notes

  • Title: Quercetin Inhibits Cardiomyocyte Apoptosis via Sirt3/SOD2/Mitochondrial Reactive Oxygen Species During Myocardial Ischemia–Reperfusion Injury

  • Authors: Xiong Da, Wang Xin, Wang Haiyu, Zhao Zicong, Ren Wenjun

  • Year: 2024

  • Citations: 6

Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Stephen Twumasi | Medicine and Dentistry | Best Researcher Award

Kwame Nkrumah University of Science and Technology, Ghana

Stephen Twumasi is an emerging biomedical researcher with a strong academic background in haematology and medical diagnostics. His academic and professional pursuits have been shaped by a passion for understanding the molecular and immunological mechanisms underlying human diseases, particularly in the context of cancer, infectious diseases, and hematological disorders. With an M.Phil. in Haematology from Kwame Nkrumah University of Science and Technology (KNUST), Ghana, and a B.Sc. in Medical Laboratory Science from the University of Cape Coast, he has demonstrated academic rigor and a deep interest in advancing health research. Stephen has actively pursued professional development through short courses in genomics, bioinformatics, systematic reviews, and community health entrepreneurship. His current research focuses on tumor immunology, developmental hematopoiesis, and molecular diagnostics for chronic and infectious diseases. Despite being in the early stages of his research career, he is keenly aware of the global health landscape and has aligned his work with critical health issues affecting Africa and beyond. With aspirations to make a meaningful contribution to global health research, Stephen combines his academic strength with continuous skill enhancement and a commitment to multidisciplinary inquiry.

Professional Profile

Education

Stephen Twumasi’s academic journey reflects a consistent focus on biomedical sciences and a deepening specialization in haematology. He earned his M.Phil. in Haematology from the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, in 2024. With a cumulative weighted average of 69.40/100 (equivalent to a CGPA of 3.8/4.0) and a thesis graded ‘A’ (Pass), he displayed academic excellence and research capability in the program. Prior to his postgraduate studies, he obtained a Bachelor of Science in Medical Laboratory Science from the University of Cape Coast in 2020, graduating with a Second Class Honors (Upper Division) and a CGPA of 3.2/4.0. His foundational education began at Adventist Senior High School in Kumasi, where he completed his West Africa Senior School Certificate Examination (WASSCE) in 2015. In addition to formal education, Stephen has completed several short courses to broaden his knowledge and research skills. These include certifications in Genomics and Bioinformatics, Systematic Review and Meta-analyses, Research Writing for Publication, One Health Basics, and Community Health Entrepreneurship. His commitment to lifelong learning and interdisciplinary training places him in a strong position for advanced research and academic engagement.

Professional Experience

Stephen Twumasi’s professional experience is grounded in his academic training in medical diagnostics and laboratory science. While specific employment roles have not been listed, it is evident that his academic journey included substantial practical exposure and laboratory-based research, particularly during his M.Phil. studies in Haematology. His postgraduate thesis work required advanced skills in diagnostic hematology, interpretation of immunological markers, and laboratory-based experimentation, reflecting real-world clinical and research competence. Through his involvement in academic programs and training workshops, Stephen has gained experience in handling molecular biology protocols, data analysis, and diagnostic procedures that are critical in modern healthcare settings. His training in community health entrepreneurship also suggests a practical understanding of the healthcare ecosystem and how scientific research can be translated into community impact. Stephen’s practical experience is further enhanced by his completion of skill-based short courses offered by reputable institutions and international collaborators. These programs have allowed him to interact with health researchers across Africa and beyond, enriching his perspectives and research readiness. Though his formal professional roles may still be developing, Stephen has built a strong foundation in biomedical practice and research through hands-on learning and academic immersion.

Research Interest

Stephen Twumasi’s research interests are firmly anchored in immunology, hematology, and molecular diagnostics, with a multidisciplinary approach that reflects current global biomedical priorities. He is particularly interested in understanding the immunological and molecular changes that occur within the tumor microenvironment and how these changes influence cancer progression, therapeutic response, and disease outcome. His interest also extends to developmental hematopoiesis and the molecular mechanisms that underlie blood cell formation, which are critical in understanding both normal physiology and disease pathology. Stephen aims to explore immunological and molecular cell alterations in age-related and inflammatory diseases, such as autoimmune disorders, chronic infections, and degenerative conditions. A significant portion of his research is directed at identifying early diagnostic biomarkers for diseases prevalent in sub-Saharan Africa, including HIV/AIDS, tuberculosis, sickle cell disease, diabetes, and kidney disease. This demonstrates his commitment to applied biomedical research that has direct implications for public health and clinical practice. By focusing on early detection and molecular profiling, Stephen envisions contributing to the development of cost-effective and scalable diagnostic tools. His research orientation is not only academically relevant but also aligned with global health equity and the fight against non-communicable and infectious diseases.

Research Skills

Stephen Twumasi has developed a strong portfolio of research skills that align with modern biomedical research demands. His training in haematology and molecular biology equips him with the ability to conduct detailed laboratory analyses and interpret complex immunological data. He is proficient in diagnostic techniques related to blood disorders and has applied this expertise during his thesis research and laboratory coursework. His skills extend into bioinformatics and genomics, where he has gained practical knowledge through certified training programs. Stephen is also trained in systematic reviews and meta-analysis, enabling him to conduct high-level literature synthesis and evidence-based assessments. His familiarity with research writing and publication, gained through specialized workshops, enhances his ability to produce and disseminate scientific findings effectively. Stephen is knowledgeable in One Health approaches, showing his capacity to conduct interdisciplinary research that bridges human, animal, and environmental health. His training in community health entrepreneurship complements his scientific skills by adding a dimension of translational research and innovation. Overall, Stephen possesses a diverse set of skills—ranging from laboratory diagnostics to scientific writing and data interpretation—that prepare him for successful academic research and collaborative scientific work.

Awards and Honors

While there are no specific awards or honors listed in Stephen Twumasi’s current profile, his academic achievements and certifications reflect commendable performance and initiative. His excellent academic record, especially his strong performance in the M.Phil. Haematology program at KNUST, suggests merit-worthy scholarly effort. His pursuit of numerous competitive and high-impact short courses—offered by organizations such as the German-West Africa Center for Global Health, MasterCard Foundation, and Genomac Institute—also highlights his selection into esteemed training programs. These certifications are often reserved for promising young researchers who demonstrate a commitment to academic and research excellence. In addition, Stephen has shown proactive engagement in international and interdisciplinary learning environments, which is itself a testament to his academic motivation and research potential. As his research career progresses and he begins to publish his work and engage in more collaborative projects, he is likely to attract competitive fellowships, grants, and awards. While he may currently be at the formative stage of his academic recognition, Stephen’s trajectory and research readiness point toward future honors and distinctions as he contributes more substantively to the scientific community.

Conclusion

Stephen Twumasi is a dedicated and promising early-career researcher whose academic focus and professional development align with global health and biomedical priorities. With a robust educational foundation in haematology and medical laboratory science, complemented by strategic certifications in genomics, bioinformatics, One Health, and research writing, he has cultivated a multidisciplinary research profile. His interests in tumor immunology, hematopoiesis, and early diagnostics of infectious and chronic diseases reflect a strong commitment to improving health outcomes through science. While his formal professional roles and recognitions are still evolving, his proactive learning approach and research enthusiasm position him as a future leader in biomedical research. He has already demonstrated the capacity for scientific inquiry and critical analysis, supported by practical lab experience and theoretical understanding. With continued mentorship, opportunities for publication, and engagement in collaborative research, Stephen is well on the path to making impactful contributions to medical science and public health. He is a suitable candidate for research-focused awards and development programs, and his future holds promise as he builds on his strengths and expands his academic influence. His dedication to advancing diagnostic and molecular research makes him a valuable asset to the scientific and health communities.

Publications Top Notes

  1. Haemato‐urological profile and asymptomatic urinary tract infection in Ghanaian steady‐state sickle cell disease patients: A case‐control study
    📚 Health Science Reports
    📅 Year: 2025
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien‐Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah‐Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.
    📈 Citations: Not available yet

  2. Assessing liver and iron markers in steady state paediatric SCD patients to ascertain the hepatic consequences of haemotransfusion: A case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: John Agyemang Sah, Benedict Sackey, Enoch Odame Anto, Allwell Adofo Ayirebi, Stephen Twumasi, Richard Vikpebah Duneeh, Ebenezer Senu, Veronica Barnor, David Boakye, Daniel Nii Martey Antonio, et al.

  3. Haemato-urological profile and asymptomatic urinary tract infection in Ghanaian steady-state sickle cell disease patients
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Richard Owusu Ansah, Samuel Essien-Baidoo, Laud Anthony W. Basing, Alexander Yaw Debrah, Enoch Odame Anto, Allwell Adofo Ayirebi, Rebecca Asiamah-Broni, Waldemer Attivor, Eric Twum Ameyaw, et al.

  4. Diagnostic value of neutrophil gelatinase-associated lipocalin and neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus individuals with reduced estimated glomerular filtration rate (eGFR): A case-control study in a municipal hospital in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Allwell Adofo Ayirebi, Wina Ivy Ofori Boadu, Benedict Sackey, Lilian Antwi-Boateng, Prince Adoba, Patrick Adu, Joseph Boachie, Stephen Twumasi, Joseph Frimpong, Emmanuel Ekow Korsah, et al.

  5. Neutrophil gelatinase-associated lipocalin and fibrinogen-to-albumin ratio are indicators of nephropathy in adult steady state sickle cell disease patients: A multicenter case-control study in Ghana
    📄 Preprint
    📅 Year: 2024
    👥 Authors: Stephen Twumasi, Enoch Odame Anto, Christian Obirikorang, Richard Kobina Dadzie Ephraim, Benedict Sackey, Vivian Paintsil, Richard Owusu Ansah, Alfred Effah, Allwell Adofo Ayirebi, Angela Opoku, et al.

 

Hui-Qiang Wei | Medicine and Dentistry | Young Researcher Award

Posted on by ScienceFather

Dr. Hui-Qiang Wei | Medicine and Dentistry | Young Researcher Award

Guangdong Cardiovascular Institute, China

Dr. Hui-Qiang Wei is a dedicated clinical researcher and medical doctor specializing in cardiac electrophysiology. Currently affiliated with the Arrhythmia Center at the Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, and Southern Medical University in Guangzhou, China, Dr. Wei has built a focused and impactful career in the management and ablation of complex cardiac arrhythmias. Born in June 1990, he has steadily advanced through rigorous academic and clinical training in cardiology, with specific attention to electrophysiological interventions. Dr. Wei’s work spans both academic research and clinical practice, with a strong emphasis on catheter ablation techniques, including those involving atrial fibrillation, supraventricular tachycardias, and ventricular arrhythmias. He has contributed to multiple peer-reviewed publications in high-impact journals, and his findings have improved the understanding and procedural outcomes of cryoballoon and substrate-based ablation methods. Additionally, Dr. Wei has engaged in international collaboration through observership at the University of Pennsylvania, further enriching his perspective and methodology. His dedication to electrophysiology, growing publication record, and translational clinical research make him an emerging leader in the field. With both depth and breadth of experience, Dr. Wei exemplifies the qualities of a promising young researcher and is well-suited for consideration in prestigious research awards.

Professional Profile

Education

Dr. Hui-Qiang Wei’s educational background is firmly rooted in the cardiovascular sciences, with a particular focus on electrophysiology. He began his medical education at Southern Medical University in Guangzhou, China, where he earned his M.D. in 2013. Demonstrating an early interest in cardiology, he continued with a Master’s degree in Electrophysiology from the Guangdong Cardiovascular Institute under the mentorship of Professor Silin Chen, completing the program in 2016. Furthering his specialization, Dr. Wei pursued his Ph.D. at Fuwai Hospital, a premier cardiovascular center in Beijing, under the guidance of Professor Jian Ma. He completed his doctoral degree in 2019, focusing on advanced electrophysiological diagnostics and interventions. His academic journey has been marked by consistency, a commitment to specialization, and mentorship under leading figures in Chinese cardiovascular medicine. Additionally, he broadened his academic exposure with a visiting observership at the Hospital of the University of Pennsylvania in 2018, where he gained valuable insights into global standards in arrhythmia management and research methodology. Dr. Wei’s education has provided him with a strong theoretical foundation, clinical training, and exposure to both national and international best practices in cardiac electrophysiology.

Professional Experience

Dr. Hui-Qiang Wei has cultivated a professional career that seamlessly integrates clinical excellence with high-quality research in cardiac electrophysiology. Since 2019, he has been a part of the Guangdong Cardiovascular Institute at Guangdong Provincial People’s Hospital, a prominent center for cardiovascular care and research. In his current role at the Arrhythmia Center, he is actively engaged in both clinical procedures and research initiatives, particularly focusing on catheter-based interventions for complex arrhythmias. Prior to this position, he completed significant training and clinical work during his master’s and doctoral programs, contributing to studies in ablation therapy under the mentorship of renowned electrophysiologists. His brief but impactful time as a visiting observer at the Hospital of the University of Pennsylvania in 2018 allowed him to observe state-of-the-art procedures and academic protocols at a world-class institution. Throughout his career, Dr. Wei has performed numerous complex arrhythmia interventions and has collaborated on multi-center studies examining the efficacy and safety of various ablation technologies. His practical experience has been reinforced by continuous involvement in academic writing and presentations, bridging the gap between clinical innovation and scholarly contribution. This dual focus on practice and research underscores his professional strength and growth trajectory in cardiac electrophysiology.

Research Interest

Dr. Hui-Qiang Wei’s primary research interest lies in the field of cardiac electrophysiology, with a specialized focus on the diagnosis and interventional management of complex cardiac arrhythmias. His research has primarily explored catheter ablation techniques, including pulmonary vein isolation, ventricular tachycardia ablation, and the use of cryoballoon ablation in varied anatomical and clinical contexts. Dr. Wei is particularly interested in understanding the electrophysiological characteristics of arrhythmogenic substrates and developing strategies to improve the precision and safety of ablation therapies. His work investigates both traditional and emerging technologies, such as second-generation cryoballoon catheters, and their application in clinical and experimental settings. Additionally, he has contributed to comparative studies assessing different ablation strategies for left posterior fascicular ventricular tachycardia, and has examined long-term outcomes in substrate-based interventions. The translational nature of his research—applying physiological insights to improve procedural outcomes—marks a significant contribution to the field. Dr. Wei’s continued interest in refining ablation protocols and identifying predictors of arrhythmia recurrence aligns with global efforts to enhance the effectiveness of interventional electrophysiology and reduce procedural risks for patients.

Research Skills

Dr. Hui-Qiang Wei possesses a wide range of research skills that support his work as a clinical scientist in the domain of cardiac electrophysiology. He is proficient in designing and executing both clinical and experimental studies, including prospective and retrospective data analyses focused on catheter ablation outcomes. His experience includes electrophysiological mapping, real-time potential recording, and advanced imaging techniques used to guide and evaluate ablation procedures. Dr. Wei has also demonstrated competence in using animal models to investigate the safety and efficacy of ablation tools, as evidenced by his co-authored study on cryoballoon ablation in a canine model. His familiarity with statistical analysis and medical software allows him to handle complex datasets, ensuring the reliability and validity of his findings. Furthermore, his involvement in multi-center studies and collaborations with prominent researchers, such as Dr. Jian Ma and Dr. Jackson J. Liang, reflects his ability to work within diverse research teams. Dr. Wei is adept at translating clinical observations into research hypotheses and subsequently testing them through structured protocols. His clear scientific writing, ability to present findings at international conferences, and continuous engagement in peer-reviewed publication demonstrate strong communication and dissemination skills essential for academic medicine.

Awards and Honors

While no specific individual awards have been listed in the provided data, Dr. Hui-Qiang Wei’s professional trajectory reflects recognition through academic appointments, publication credits, and invited presentations that signal growing acknowledgment within the scientific and clinical community. Notably, he was selected for an oral presentation at the Asia Pacific Heart Rhythm Society (APHRS) 2017 conference, which is a respected forum for cardiac electrophysiologists in the Asia-Pacific region. His collaborative work has been published in leading cardiology journals such as Heart Rhythm, Europace, and Journal of Cardiovascular Electrophysiology, indicating the high quality and relevance of his research. Being first author or co-author on such impactful studies suggests trust and esteem from his mentors and research collaborators. His visiting observer role at the Hospital of the University of Pennsylvania also highlights academic merit, as such opportunities are typically offered to promising researchers with demonstrable academic potential. Although explicit awards or honors are not detailed, Dr. Wei’s academic output and the caliber of his institutional affiliations imply ongoing professional recognition and the potential for future accolades in his field.

Conclusion

Dr. Hui-Qiang Wei exemplifies the qualities of a dedicated and capable young researcher whose contributions to cardiac electrophysiology are both meaningful and steadily expanding. His focused academic background, hands-on clinical experience, and a growing portfolio of peer-reviewed publications position him as an emerging leader in arrhythmia research and intervention. He demonstrates a clear understanding of current challenges in the field and actively works toward improving procedural safety and efficacy through data-driven methods. His commitment to both research and patient care, reinforced by international exposure and collaboration, reflects a balanced professional maturity that is commendable for a researcher of his career stage. With continued development in research leadership, grant participation, and broader dissemination of his work, Dr. Wei is likely to make substantial long-term contributions to cardiovascular medicine. His background, experience, and vision align well with the purpose of the Young Researcher Award, making him a strong candidate deserving of recognition. As he continues to evolve in his academic and clinical endeavors, Dr. Wei is poised to become an influential figure in advancing electrophysiological practice and research both in China and internationally.

Publication Top Notes

  1. Association between age at diagnosis of atrial fibrillation and subsequent risk of ischemic stroke
    Authors: Y. Cheng, H. Deng, H. Wei, Y. Xue, Z. Wu
    Journal: Journal of the American Heart Association
    Year: 2025

  2. A giant left atrial appendage aneurysm with incessant atrial tachycardia
    Authors: H. Wei, Y. Xue, S. Wu, H. Liao
    Journal: Journal of Cardiovascular Electrophysiology
    Year: 2025

  3. A novel mutation in hERG gene associated with azithromycin-induced acquired long QT syndrome
    Authors: Y. Cheng, Y. Wu, H. Wei, L. Liu, W. Bi
    Journal: Molecular Biology Reports
    Year: 2024
    Citations: 1

 

Heba Jalloun | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Heba Jalloun | Medicine and Dentistry | Best Researcher Award

King Fahd Armed Forces Hospital from Saudi Arabia

Dr. Heba Essam Jalloun is a highly accomplished consultant in colorectal, minimally invasive, and robotic surgery, currently based at King Fahd Armed Forces Hospital (KFAFH) in Jeddah, Saudi Arabia. With over two decades of extensive clinical, academic, and research experience, Dr. Jalloun has demonstrated a steadfast commitment to the advancement of surgical practice, training, and innovation in her field. She earned her Bachelor’s degree in Medicine and Surgery from King Abdul-Aziz University in 2000, followed by the Saudi Specialty Certificate in General Surgery in 2008. Her international training includes two prestigious fellowships in South Korea focusing on minimally invasive, laparoscopic, robotic, oncology, and pelvic floor surgeries. Beyond her clinical responsibilities, she actively participates in training future surgeons as the Director of the General Surgery Saudi Board Residency Program at KFAFH. Dr. Jalloun is widely recognized for her contributions as a speaker at national and international conferences, as well as her active participation in surgical societies across Saudi Arabia, Europe, and Asia. Her work during the COVID-19 pandemic as a frontliner and her extensive involvement in global research collaborations further emphasize her dedication to both patient care and the academic community.

Professional Profile

Education

Dr. Heba Jalloun’s educational foundation is rooted in excellence and international exposure. She began her medical education at King Abdul-Aziz University, where she earned her Bachelor’s degree in Medicine and General Surgery (MBChB) between 1994 and 2000. After passing the Saudi License Exam in 2000, she pursued her residency in General Surgery through the Saudi Board program, completing her Saudi Specialty Certificate in General Surgery (SSC-SURG) in 2008. Her postgraduate training was distinguished by a strong focus on advanced surgical techniques, particularly in minimally invasive procedures. She furthered her expertise through two consecutive fellowships in South Korea: one in Minimal Invasive Surgery, Laparoscopic & Robotic Surgery for Colorectal Diseases (2015–2016), and the second in Oncology, Proctology, and Pelvic Floor Surgery (2017). These fellowships were undertaken at the Catholic University of Korea, Seoul St. Mary’s Hospital, providing her with global perspectives and high-level surgical training. Dr. Jalloun also acquired numerous certifications including ATLS instructor, Basic Surgical Skills instructor, Advanced Cardiac Life Support, and the Train of Trainer (TOT) program. Her dedication to continuous professional development is further evident through her involvement in structured surgical courses and certifications that support both clinical excellence and teaching proficiency.

Professional Experience

Dr. Heba Jalloun’s professional career spans over two decades of dedicated service, with a significant focus on general, colorectal, and robotic surgery. She began her journey in clinical practice as a resident in family medicine from 2001 to 2003, then transitioned into general surgery residency at Northwest Armed Forces Hospital and King Abdulaziz & Oncology Center from 2003 to 2008. After receiving her board certification, she was appointed as a Registrar and later an Assistant Consultant in General Surgery at KFAFH. Her expertise and leadership were recognized as she advanced to the roles of General Surgery Consultant in 2014 and Colorectal, Minimally Invasive, and Robotic Surgery Consultant in 2018. In 2022, she was appointed Director of the Saudi Board General Surgery Residency Program at KFAFH. Alongside clinical duties, Dr. Jalloun has led and organized numerous simulation-based training courses, contributed significantly to resident education, and participated in advanced surgical workshops both nationally and internationally. Her role during the COVID-19 pandemic as a frontliner and key investigator in global surgical research further highlights her dynamic and compassionate leadership. She is also an active member of surgical societies in Saudi Arabia and abroad, bridging international best practices with local healthcare advancements.

Research Interests

Dr. Heba Jalloun’s research interests are aligned closely with her clinical expertise in colorectal surgery, minimally invasive techniques, and oncology. She is deeply engaged in advancing surgical methodologies through evidence-based studies and is particularly focused on Enhanced Recovery After Surgery (ERAS) protocols, outcomes of laparoscopic procedures, and the management of colorectal diseases. Her international collaborations reflect her commitment to global health challenges, especially in the context of the COVID-19 pandemic, where she co-authored several high-impact publications addressing surgical delays, postoperative complications, and vaccine safety related to surgical outcomes. Additionally, she is interested in surgical education, clinical audits, and quality improvement projects—particularly those improving patient discharge efficiency and postoperative recovery. Dr. Jalloun has also explored surgical techniques in emergency abdominal procedures and rare case reports, including drug addiction among high school students. Her current and ongoing research includes hospital-based projects, international multicenter cohort studies, and case series publications. Through this multifaceted research approach, Dr. Jalloun aims to bridge gaps between clinical practice and academic inquiry, ultimately contributing to improved patient safety, surgical precision, and innovation in healthcare systems across the region and globally.

Research Skills

Dr. Heba Jalloun possesses a strong portfolio of research skills encompassing clinical study design, data collection, analysis, publication, and academic presentations. She has served as a principal investigator for several international multicenter studies focused on elective cancer surgery, acute cholecystitis, and surgical outcomes during the COVID-19 pandemic. Her contributions demonstrate proficiency in conducting prospective cohort studies, managing collaborative global datasets, and interpreting clinical implications across diverse healthcare settings. Additionally, Dr. Jalloun is skilled in writing and reviewing scientific manuscripts, poster presentations, and case reports. Her research on ERAS protocols, laparoscopic surgery outcomes, and oncologic safety has been published in respected international journals. She actively contributes to hospital-based quality improvement projects and is proficient in coordinating multidisciplinary research teams. Dr. Jalloun’s training experience also equips her with excellent skills in presenting at international symposiums, conducting workshops, and teaching evidence-based surgical practices. Her ability to integrate research into clinical practice makes her an asset to both academic and medical institutions. Furthermore, her dedication to mentorship and supervision of trainees in research-related tasks reinforces her role as a leader in academic medicine and clinical education.

Awards and Honors

Dr. Heba Jalloun has received multiple awards and honors in recognition of her clinical excellence, teaching capabilities, and service to the healthcare community. She was honored with the Best Instructor and Teacher award at King Fahd Armed Forces Hospital (KFAFH) for the academic year 2019–2020, reflecting her impactful contributions to surgical education. Earlier in her career, she was recognized as the Best Senior Registrar in 2010–2011, showcasing her exceptional performance during residency. Her role as an instructor in ATLS and Basic Surgical Skills courses since 2005 further highlights her longstanding commitment to surgical training. Dr. Jalloun received certificates of appreciation for her contributions to patient safety and experience in both 2021 and 2023, underlining her dedication to improving healthcare quality. During the COVID-19 pandemic, she was acknowledged for her invaluable service as a frontliner and key investigator in international research collaborations. Additionally, she has been commended for her participation as a speaker in numerous national and international symposiums. These accolades collectively reflect her multifaceted contributions as a surgeon, educator, researcher, and leader committed to advancing the field of surgery and patient care at both national and global levels.

Conclusion

In conclusion, Dr. Heba Essam Jalloun exemplifies the qualities of a distinguished surgeon, educator, and researcher, making her a strong candidate for the Best Researcher Award. Her career demonstrates an exceptional balance between clinical practice, academic leadership, and impactful research contributions. Through her international training in advanced surgical techniques and ongoing participation in global collaborative studies, she has significantly enriched both patient outcomes and medical knowledge. Her work during the COVID-19 pandemic, alongside her numerous publications and hospital projects, highlights her commitment to addressing real-world challenges with scientific rigor. Dr. Jalloun’s leadership in surgical education, evident from her role as Director of the Saudi Board Residency Program, further establishes her as a mentor and role model for future generations of surgeons. With multiple awards recognizing her teaching, service, and research, she has shown unwavering dedication to excellence in healthcare. While her work is already commendable, expanding her independent research leadership and engaging in broader interdisciplinary projects could further enhance her impact. Overall, Dr. Jalloun’s credentials and achievements reflect not only her expertise but also her vision for continuous innovation and improvement in surgery and medical education. She is a highly deserving candidate for this prestigious recognition.

Publications Top Notes

  • Title: Influence of the Enhanced Recovery After Surgery Protocol on Postoperative Inflammation and Short-Term Postoperative Surgical Outcomes After Colorectal Cancer Surgery

  • Authors: Jalloun Heba Essam (H.E.), Lee In Kyu (I.K.), Kim Min-ki (M.), Lee Yoon-suk (Y.), Jeon Hae-myung (H.)

  • Year: 2020

  • Citations: 19

Xiao-Yi Xiong | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Xiao-Yi Xiong | Medicine and Dentistry | Best Researcher Award

Associated Professor from Chengdu University of Traditional Chinese Medicine, China

Xiong Xiaoyi is a distinguished researcher and associate professor specializing in neurology, with a particular focus on neuroprotection and brain injury mechanisms. With a robust academic foundation, he earned his PhD from the Army Medical University in 2018, and his work has earned him recognition as a leading researcher in his field. His academic journey has been complemented by a series of prestigious awards, such as the Sichuan Outstanding Youth Science Fund and the Third Prize in the Shandong Medical Science and Technology Progress Award. Xiong’s research primarily addresses ischemic stroke, intracerebral hemorrhage, and neurodegeneration, making significant strides in understanding molecular mechanisms like lactate production, protein lactylation, and astrocyte functions. As an associate professor at Chengdu University of Traditional Chinese Medicine, he has expanded his influence, integrating traditional Chinese medicine techniques with modern neurobiological research. He has published numerous influential papers, showcasing his expertise in neurochemistry, neuroimmunology, and therapeutic strategies. His multidisciplinary approach has made him an asset to various professional committees, where he actively contributes to advancing the field. Xiong’s combination of research depth, academic leadership, and innovative thinking underscores his status as a prominent figure in neurology.

Professional Profile

Education

Xiong Xiaoyi’s academic journey is marked by rigorous training in clinical medicine and neurology. He completed his undergraduate studies at Luzhou Medical College in 2012, where he developed a strong foundation in clinical medicine. His dedication to advancing his knowledge led him to pursue a Master’s degree at the Second Affiliated Hospital of the Third Military Medical University, completing it in 2015. Building on this, he embarked on a PhD program at the same institution, culminating in his doctoral degree in 2018. His doctoral research focused on neuroprotection in ischemic stroke, and his innovative work earned him numerous accolades, including the title of Outstanding PhD Graduate. His doctoral education enabled him to combine cutting-edge research with clinical applications, laying the groundwork for his future contributions in neurology. Xiong’s educational experiences have not only provided him with technical expertise but also honed his capacity for interdisciplinary collaboration, particularly with traditional Chinese medicine. This combination of formal education and practical experience has equipped him with the tools to pursue pioneering research in neurodegenerative diseases and stroke recovery, positioning him as a leader in the field.

Professional Experience

Xiong Xiaoyi’s professional experience spans both academic and clinical domains, showcasing his versatility and expertise in neurology. After completing his PhD in 2018, he took on the role of lecturer at the Department of Neurology at the Second Affiliated Hospital of the Third Military Medical University, where he contributed to both teaching and research. During this time, Xiong’s clinical experience in stroke management complemented his research on brain injury, allowing him to apply theoretical knowledge in real-world settings. In 2019, he transitioned to an associate professor position at the College of Acupuncture and Tuina at Chengdu University of Traditional Chinese Medicine. Here, he has broadened his research focus to explore how traditional Chinese medicine, such as acupuncture, can complement modern neurobiological therapies. His academic responsibilities also include supervising master’s students, further shaping the next generation of neurology researchers. Throughout his career, Xiong has demonstrated a commitment to advancing both theoretical knowledge and clinical practice, making meaningful contributions to the fields of stroke recovery and neurodegeneration. His dual focus on research and education has allowed him to remain at the forefront of both scientific inquiry and academic mentorship.

Research Interests

Xiong Xiaoyi’s research interests are centered on neuroprotection, brain injury, and neurodegenerative diseases, particularly focusing on ischemic stroke and intracerebral hemorrhage. His work aims to elucidate the molecular and cellular mechanisms underlying brain injury, with a specific focus on astrocyte functions and the role of lactate production in neurodegeneration. A key aspect of his research involves exploring how electroacupuncture can provide neuroprotective effects by modulating metabolic pathways, such as lactylation and succinylation. Xiong is also deeply invested in understanding the pathophysiological processes involved in aging-related brain injuries and the potential for rejuvenation through targeted molecular therapies. His research also extends to studying the activation of glial cells and their role in exacerbating brain injury, as well as investigating how metabolic changes in the brain influence these processes. By bridging the gap between traditional medicine and modern neuroscience, Xiong aims to develop innovative therapeutic strategies that can improve patient outcomes in neurodegenerative diseases. His interdisciplinary research approach, integrating traditional Chinese medicine with neurobiology, sets him apart in his field, allowing for novel insights and potential treatments in the neuroprotective domain.

Research Skills

Xiong Xiaoyi’s research skills are vast and multifaceted, spanning molecular biology, neurochemistry, and neuroimmunology. He possesses expertise in cutting-edge techniques, including proteomics, metabolomics, and bioinformatics, which he uses to unravel the complexities of brain injury and neurodegeneration. His ability to design and execute intricate experiments is demonstrated through his extensive use of animal models, where he investigates ischemic stroke and intracerebral hemorrhage. Xiong’s work also integrates advanced biochemical analyses, including lactate and succinylation profiling, to understand metabolic changes during brain injury. His expertise in neuroinflammation and the roles of astrocytes and glial cells in neurodegeneration further highlights his technical capabilities. Additionally, Xiong’s research often employs traditional Chinese medicine techniques, such as electroacupuncture, to explore their potential neuroprotective effects, bridging modern science with ancient healing practices. His proficiency in these interdisciplinary methodologies enables him to contribute novel insights into therapeutic strategies for stroke recovery and neurodegenerative diseases. Beyond technical skills, Xiong’s leadership in research teams and ability to collaborate with international experts underscores his strong communication and mentorship abilities, making him a well-rounded researcher in his field.

Awards and Honors

Xiong Xiaoyi’s exceptional contributions to neurology and neuroprotection have earned him numerous prestigious awards and honors throughout his career. In 2016, he received the Excellent Master’s Thesis award from both the Third Military Medical University and the PLA, underscoring his early promise in research. His doctoral research earned him the Outstanding PhD Graduate distinction from the Army Medical University in 2018, a testament to the impact of his work in the field of neuroprotection. His innovative contributions have also been recognized by national and provincial authorities, including the Sichuan Outstanding Youth Science Fund and the Sichuan Provincial Special Expert (Young Thousand Talents Program) award in 2021. Xiong’s work has led to multiple accolades in scientific research, such as the Excellent Poster Award at the 12th Chinese Neuroscience Annual Meeting and the Third Prize in the Shandong Medical Science and Technology Progress Award. These honors reflect the high regard in which he is held by the academic and medical communities. His ability to secure competitive funding, including the Chongqing Graduate Research Innovation Fund, further highlights his credibility and standing as a leading researcher in neurology and stroke recovery.

Conclusion

Xiong Xiaoyi is a highly accomplished researcher whose work in neurology has significantly advanced our understanding of stroke, brain injury, and neurodegenerative diseases. His innovative research, spanning both clinical and basic science, has placed him at the forefront of neuroprotective therapies, particularly in the areas of ischemic stroke and intracerebral hemorrhage. Xiong’s ability to integrate traditional Chinese medicine with modern neurobiological approaches sets him apart as a pioneer in his field. His numerous awards and honors, along with his leadership roles in professional societies, highlight his influence and recognition within the academic and medical communities. Xiong’s multidisciplinary research, mentorship, and contributions to the field have solidified his reputation as a leader in neurology, and he continues to make significant strides in developing novel therapeutic strategies. With a clear focus on improving patient outcomes and advancing scientific understanding, Xiong Xiaoyi’s future contributions are poised to leave a lasting impact on neurology and neuroprotective medicine.

Publications Top Notes

  1. Title: Electroacupuncture Pretreatment Reduces Ischemic Brain Injury by Inhibiting the Lactate Production and Its Derived Protein Lactylation Formation
    Authors: X. Pan, Xinru; Y. Zhang, Yaodan; Y.H. Gan, Yuan Hui; Y. Tang, Yong; X. Xiong, Xiaoyi
    Year: 2025
    Journal: CNS Neuroscience and Therapeutics

  2. Title: Astrocyte-derived lactate aggravates brain injury of ischemic stroke in mice by promoting the formation of protein lactylation
    Authors: X. Xiong, Xiaoyi; X. Pan, Xinru; X. Luo, Xiaxia; S. Yu, Shuguang; Q.Q. Yang, Qingwu Qian
    Year: 2024
    Citations: 13
    Journal: Theranostics

  3. Title: A Novel Mutation in an MNGIE Patient Presenting with More Prominent Neurological Symptoms than GI Symptoms
    Authors: X. Chen, Xiaoyan; X. Xiong, Xiaoyi; S. Liu, Shu; R. Xu, Rui; Q.Q. Yang, Qingwu Qian
    Year: 2023
    Journal: Neurology India

  4. Title: Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice
    Authors: Q. Chen, Qiong; T. Zhou, Ting; J. Yuan, Junjie; C. Liu, Chang; Q.Q. Yang, Qingwu Qian
    Year: 2023
    Citations: 4
    Journal: Frontiers in Pharmacology